NOV 25, 2015 05:02 AM PST

Shutting Off Tumor Cells


Researchers at the Mayo Clinic's Florida campus are trying to shut down cancer cell growth with MicroRNA proteins. While cell division and growth is normal in healthy cells, in cancer cells the process is disrupted. The researchers led by Dr. Panos Ansastasiadis, discovered a kind of code that they suggest can shut off tumor growth.

They discovered that adhesion proteins - the glue that keeps cells together - interact with the part of the cell that manufacture proteins called microRNAs (miRNAs). The miRNAs orchestrate whole cellular programs by simultaneously regulating expression of a group of genes. In healthy cells that come into contact with each other, a specific subset of miRNAs suppresses genes that promote cell growth. When this adhesion is disrupted in cancer cells, these miRNAs don't function properly and cancer cells multiply out of control. The investigators showed in laboratory experiments that restoring the normal miRNA levels in cancer cells can reverse the harmful tumor producing cell growth.
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
NOV 05, 2018
Videos
NOV 05, 2018
How UV Rays Cause Aging and Skin Cancer
We know that UV rays can do damage to our DNA - but how?...
NOV 05, 2018
Space & Astronomy
NOV 05, 2018
The Mystery Behind Oumuamua Continues...
Last year, Oumuamua became the first-known interstellar object to be identified by astronomers as it passed through our solar system. At first, astronomers...
NOV 17, 2018
Videos
NOV 17, 2018
Using Genetic Research to Improve Animal Conservation and Care
A group of Peters's Angolan colobus monkeys were brought to US zoos from East Africa in the 80s, but little is known about them....
NOV 20, 2018
Videos
NOV 20, 2018
A Major Grant Aims to Improve our Understanding of Age-related Cognitive Decline
The American Heart Association has teamed up with the Allen Initiative in Brain Health and Cognitive Impairment to award the Salk Institute $19.2 million....
NOV 24, 2018
Videos
NOV 24, 2018
Gene signature predicting immune therapy
An experiment is conducted upon ECM to decide for a novel biomarker, that will help to deciding which patient can enroll fro immune therapy....
DEC 05, 2018
Cancer
DEC 05, 2018
Zika virus as a weapon against brain cancer
Glioblastoma is the most aggressive type of Brain Cancer with an average survival rate of less than two years with treatment. So what if there could be a cure for this type of cancer....
Loading Comments...